Mankind Pharma acquires Bharat Serums from Advent International for ₹13,630 crore. Learn More
Biotechnology
R&D & Innovation
Biotechnology
Pioneering Advanced Therapies from Living Cells
Pioneering Advanced
Therapies from Living Cells
Biotechnology, the science of using living cells to create medicines, has become a leading source of therapies for patients. Since the mid-1980s, several breakthrough discoveries in biology, life sciences, and medicine laid the foundation for this revolutionary class of medicines.
Commitment to
Biosimilars

Mankind Pharma, with its focus on developing affordable medicines, embarked on a journey to create high-quality biosimilars. These biosimilars are designed to reliably serve both doctors and patients.

Our primary focus areas are:

Oncology
Oncology
Chronic Inflammatory Diseases
Chronic Inflammatory Diseases
Metabolic and Lifestyle Disorders
Metabolic and Lifestyle Disorders
State-of-the-Art
R&D Infrastructure
To achieve the goal of producing affordable, high-quality biosimilars, Mankind Pharma has invested in advanced R&D infrastructure. Dedicated teams of experienced scientists work on the development and delivery of these medicines.
State-of-the-Art R&D Infrastructure
Core Capabilities in Biosimilar Development
Core Capabilities in
Biosimilar Development
Molecular biology and DNA manipulation for genetic engineering
Product
characterisation
Protein isolation and
purification
Cell culture scale-up and
fermentation
Cell line development, single-cell cloning, and cell banking